Presenter: Simon Drescher, PD Dr (he/him/his) – Phospholipid Research Center
Presenter: Peter van Hoogevest, PhD (he/him/his) – Pharmanovation Consulting
Presenter: Paulina Skupin-Mrugalska, PhD (she/her/hers) – Poznan University of Medical Sciences
Presenter: Paola Luciani, PhD (she/her/hers) – University of Bern
Presenter: Mans Broekgaarden, PhD (he/him/his) – Grenoble-Alpes University, Inserm
Presenter: Davide Brambilla, PhD (he/him/his) – Université de Montreal
Presenter: Manuela Gaspar, PhD (she/her/hers) – Faculty of Pharmacy, Universidade de Lisboa
Presenter: Félix Sauvage, PharmD, PhD (he/him/his) – Ghent University
Presenter: Simon Drescher, PD Dr (he/him/his) – Phospholipid Research Center
### he/him/his @@@ Peter van Hoogevest, PhD (he/him/his) – Pharmanovation Consulting ### 2294490###Presenter###CEO###Pharmanovation Consulting###Presenter: Peter van Hoogevest, PhD (he/him/his) – Pharmanovation Consulting
### he/him/his @@@ Paulina Skupin-Mrugalska, PhD (she/her/hers) – Poznan University of Medical Sciences ### 2294491###Presenter###Assistant Professor###Poznan University of Medical Sciences###Presenter: Paulina Skupin-Mrugalska, PhD (she/her/hers) – Poznan University of Medical Sciences
### she/her/hers @@@ Paola Luciani, PhD (she/her/hers) – University of Bern ### 2294492###Presenter###Full Professor Pharmaceutical Technology###University of Bern###Presenter: Paola Luciani, PhD (she/her/hers) – University of Bern
### she/her/hers @@@ Mans Broekgaarden, PhD (he/him/his) – Grenoble-Alpes University, Inserm ### 2294494###Presenter###Tenured Principal Investigator###Grenoble-Alpes University, Inserm###Presenter: Mans Broekgaarden, PhD (he/him/his) – Grenoble-Alpes University, Inserm
### he/him/his @@@ Davide Brambilla, PhD (he/him/his) – Université de Montreal ### 1612200###Presenter###Professor###Université de Montreal###Presenter: Davide Brambilla, PhD (he/him/his) – Université de Montreal
### he/him/his @@@ Manuela Gaspar, PhD (she/her/hers) – Faculty of Pharmacy, Universidade de Lisboa ### 2294495###Presenter###Researcher###Faculty of Pharmacy, Universidade de Lisboa###Presenter: Manuela Gaspar, PhD (she/her/hers) – Faculty of Pharmacy, Universidade de Lisboa
### she/her/hers @@@ Félix Sauvage, PharmD, PhD (he/him/his) – Ghent University ### 1612233###Presenter###Associate professor###Ghent University###Presenter: Félix Sauvage, PharmD, PhD (he/him/his) – Ghent University
### he/him/hisModerator & Presenter: Avi Schroeder
Moderator & Presenter: Daniel Heller, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center
Presenter: Christine Allen, Dr. – University of Toronto
Presenter: Bowen Li, PhD (he/him/his) – University of Toronto
Presenter: Theresa Reineke
Presenter: Daniel F. Quevedo, PhD (he/him/his) – METiS Therapeutics
Presenter: Daniel Reker, DrSc (he/him/his) – Duke University
Presenter: Yosi Shamay, PhD – Technion, Israel Institute of technology
.png)
.png)
Moderator & Presenter: Avi Schroeder
### @@@ Daniel Heller, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center ### 1612220###Moderator & Presenter###Member/Professor###Memorial Sloan Kettering Cancer Center###Moderator & Presenter: Daniel Heller, PhD (he/him/his) – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Christine Allen, Dr. – University of Toronto ### 1670345###Presenter###Professor ###University of Toronto###Presenter: Christine Allen, Dr. – University of Toronto
### @@@ Bowen Li, PhD (he/him/his) – University of Toronto ### 2315657###Presenter###Assistant Professor###University of Toronto###Presenter: Bowen Li, PhD (he/him/his) – University of Toronto
### he/him/his @@@ Theresa Reineke ### 2296287###Presenter#########Presenter: Theresa Reineke
### @@@ Daniel F. Quevedo, PhD (he/him/his) – METiS Therapeutics ### 2315198###Presenter###Associate Director, Business Development and Strategy###METiS Therapeutics###Presenter: Daniel F. Quevedo, PhD (he/him/his) – METiS Therapeutics
### he/him/his @@@ Daniel Reker, DrSc (he/him/his) – Duke University ### 2315200###Presenter###Assistant Professor###Duke University###Presenter: Daniel Reker, DrSc (he/him/his) – Duke University
### he/him/his @@@ Yosi Shamay, PhD – Technion, Israel Institute of technology ### 1724410###Presenter###Assistant Professor, Faculty of Biomedical Engineering###Technion, Israel Institute of technology###Presenter: Yosi Shamay, PhD – Technion, Israel Institute of technology
###Moderator & Presenter: Simon Matoori, PhD – Université de Montréal Montreal, Canada
Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
Presenter: Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company
Presenter: Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH
Presenter: Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology
Presenter: David Kang – Halozyme Therapeutics
Presenter: Ron J. Pettis, MS, PhD – BD
Presenter: Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School
Presenter: Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan
.png)
Moderator & Presenter: Simon Matoori, PhD – Université de Montréal Montreal, Canada
### @@@ Beate Bittner, PhD – F. Hoffmann - La Roche ### 2042475###Moderator & Presenter###Global Head Product Optimization###F. Hoffmann - La Roche###Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
### @@@ Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company ### 2042477###Presenter###Global Technical Director###Gaylord Chemical Company###Presenter: Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company
### he/him/his @@@ Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH ### 2300130###Presenter###Technical Development Leader###Roche Diagnostics GmbH###Presenter: Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH
### she/her/hers @@@ Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology ### 2300133###Presenter###Researcher ###Italian Institute of Technology###Presenter: Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology
### she/her/hers @@@ David Kang – Halozyme Therapeutics ### 2296069###Presenter###Director, Drug Delivery###Halozyme Therapeutics###Presenter: David Kang – Halozyme Therapeutics
### @@@ Ron J. Pettis, MS, PhD – BD ### 2300131###Presenter###Sr. Director Translational Science###BD###Presenter: Ron J. Pettis, MS, PhD – BD
### @@@ Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School ### 1551415###Presenter###Associate Professor###MIT, Harvard Medical School###Presenter: Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School
### @@@ Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan ### 2300132###Presenter###Full Professor; Head of Department of Pharmaceutical Sciences###University of Milan###Presenter: Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan
### she/her/hersModerator & Presenter: Ali Rajabi-Siahboomi, PhD (he/him/his) – Colorcon
Moderator & Presenter: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep
Moderator: Daniel Bar-Shalom, Pharmacist (he/him/his) – University of Copenhagen
Presenter: Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences
Presenter: Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd
Presenter: David J. Brayden, PhD (he/him/his) – University College Dublin
Presenter: Felix Hofmann
Presenter: Anette Müllertz (she/her/hers) – University of Copenhagen
Presenter: Xiaoling Li, PhD (he/him/his) – University of the Pacific
Presenter: Tom Kamperman, PhD (he/him/his) – IamFluidics BV
Presenter: Johannes Khinast
.png)
.png)
.png)
Moderator & Presenter: Ali Rajabi-Siahboomi, PhD (he/him/his) – Colorcon
### he/him/his @@@ Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep ### 2015397###Moderator & Presenter###CEO###MeltPrep###Moderator & Presenter: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep
### ¯\_(ツ)_/¯ @@@ Daniel Bar-Shalom, Pharmacist (he/him/his) – University of Copenhagen ### 1655130###Moderator###Associate Professor###University of Copenhagen###Moderator: Daniel Bar-Shalom, Pharmacist (he/him/his) – University of Copenhagen
### he/him/his @@@ Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences ### 1655131###Presenter###Research Professor###Strathclyde Institute Of Pharmacy and BioMedical Sciences###Presenter: Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences
### @@@ Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd ### 2075323###Presenter###Technical Director###Shin-Etsu Chemical Company Ltd###Presenter: Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd
### he/him/his @@@ David J. Brayden, PhD (he/him/his) – University College Dublin ### 1655133###Presenter###Professor of Advanced Drug Delivery###University College Dublin###Presenter: David J. Brayden, PhD (he/him/his) – University College Dublin
### he/him/his @@@ Felix Hofmann ### 2296136###Presenter#########Presenter: Felix Hofmann
### @@@ Anette Müllertz (she/her/hers) – University of Copenhagen ### 1655127###Presenter###Professor###University of Copenhagen###Presenter: Anette Müllertz (she/her/hers) – University of Copenhagen
### she/her/hers @@@ Xiaoling Li, PhD (he/him/his) – University of the Pacific ### 2296137###Presenter###Professor###University of the Pacific###Presenter: Xiaoling Li, PhD (he/him/his) – University of the Pacific
### he/him/his @@@ Tom Kamperman, PhD (he/him/his) – IamFluidics BV ### 2343374###Presenter###CTO & co-founder###IamFluidics BV###Presenter: Tom Kamperman, PhD (he/him/his) – IamFluidics BV
### he/him/his @@@ Johannes Khinast ### 2296138###Presenter#########Presenter: Johannes Khinast
###.png)
Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
Moderator & Presenter: Simon Matoori, PhD – Université de Montréal Montreal, Canada
Presenter: Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company
Presenter: Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH
Presenter: Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology
Presenter: David Kang – Halozyme Therapeutics
Presenter: Ron J. Pettis, MS, PhD – BD
Presenter: Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School
Presenter: Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan
Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
### @@@ Simon Matoori, PhD – Université de Montréal Montreal, Canada ### 1724411###Moderator & Presenter###Professor###Université de Montréal Montreal, Canada###Moderator & Presenter: Simon Matoori, PhD – Université de Montréal Montreal, Canada
### @@@ Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company ### 2042477###Presenter###Global Technical Director###Gaylord Chemical Company###Presenter: Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company
### he/him/his @@@ Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH ### 2300130###Presenter###Technical Development Leader###Roche Diagnostics GmbH###Presenter: Eva Rosenberg, PhD (she/her/hers) – Roche Diagnostics GmbH
### she/her/hers @@@ Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology ### 2300133###Presenter###Researcher ###Italian Institute of Technology###Presenter: Annalisa Palange, PhD in Medical Biotechnologies (she/her/hers) – Italian Institute of Technology
### she/her/hers @@@ David Kang – Halozyme Therapeutics ### 2296069###Presenter###Director, Drug Delivery###Halozyme Therapeutics###Presenter: David Kang – Halozyme Therapeutics
### @@@ Ron J. Pettis, MS, PhD – BD ### 2300131###Presenter###Sr. Director Translational Science###BD###Presenter: Ron J. Pettis, MS, PhD – BD
### @@@ Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School ### 1551415###Presenter###Associate Professor###MIT, Harvard Medical School###Presenter: Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School
### @@@ Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan ### 2300132###Presenter###Full Professor; Head of Department of Pharmaceutical Sciences###University of Milan###Presenter: Paola Minghetti, PharmD, PhD (she/her/hers) – University of Milan
### she/her/hersChair: Mariah Arral (she/her/hers) – Carnegie Mellon University
Co-Chair: Leila Arabi, PharmD PhD – Pharmaceutical Nanotechnology Department, School of Pharmacy
Speaker: Christine Horejs, PhD – Nature Reviews Bioengineering
Speaker: Maria J. Vicent, Prof (she/her/hers) – Prince Felipe Research Center
Chair: Mariah Arral (she/her/hers) – Carnegie Mellon University
### she/her/hers @@@ Leila Arabi, PharmD PhD – Pharmaceutical Nanotechnology Department, School of Pharmacy ### 2338903###Co-Chair###Assistant Professor###Pharmaceutical Nanotechnology Department, School of Pharmacy###Co-Chair: Leila Arabi, PharmD PhD – Pharmaceutical Nanotechnology Department, School of Pharmacy
### @@@ Christine Horejs, PhD – Nature Reviews Bioengineering ### 2408248###Speaker###Chief Editor###Nature Reviews Bioengineering###Speaker: Christine Horejs, PhD – Nature Reviews Bioengineering
### @@@ Maria J. Vicent, Prof (she/her/hers) – Prince Felipe Research Center ### 1612184###Speaker###Coordinator Cancer Program and Head of Polymer Therapeutics Lab###Prince Felipe Research Center###Speaker: Maria J. Vicent, Prof (she/her/hers) – Prince Felipe Research Center
### she/her/hersModerator & Presenter: David Kang – Halozyme Therapeutics
Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
Presenter: Sylvain Huille, PhD (he/him/his) – Sanofi
Presenter: Hannie Shih, PhD (she/her/hers) – Eli Lilly and Company
Presenter: Marie Printz (she/her/hers) – Halozyme, Inc.
Presenter: Nicole Buist, PhD (she/her/hers) – MSD
Presenter: Manuel Sanchez-Felix, PhD (he/him/his) – Halozyme
Presenter: Kate L. Harris (she/her/hers) – AstraZeneca
Presenter: Gerard Bruin (he/him/his) – Pharmacokinetic Sciences / Novartis
Presenter: Marta Venczel (she/her/hers) – Sanofi
.png)
Moderator & Presenter: David Kang – Halozyme Therapeutics
### @@@ Beate Bittner, PhD – F. Hoffmann - La Roche ### 2042475###Moderator & Presenter###Global Head Product Optimization###F. Hoffmann - La Roche###Moderator & Presenter: Beate Bittner, PhD – F. Hoffmann - La Roche
### @@@ Sylvain Huille, PhD (he/him/his) – Sanofi ### 2296073###Presenter###Scientist - Group Head###Sanofi###Presenter: Sylvain Huille, PhD (he/him/his) – Sanofi
### he/him/his @@@ Hannie Shih, PhD (she/her/hers) – Eli Lilly and Company ### 2296075###Presenter###Sr Advisor###Eli Lilly and Company###Presenter: Hannie Shih, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Marie Printz (she/her/hers) – Halozyme, Inc. ### 2077008###Presenter###Executive Director Bioanalytical & Nonclinical Sciences###Halozyme, Inc.###Presenter: Marie Printz (she/her/hers) – Halozyme, Inc.
### she/her/hers @@@ Nicole Buist, PhD (she/her/hers) – MSD ### 2296072###Presenter###Senior Director###MSD###Presenter: Nicole Buist, PhD (she/her/hers) – MSD
### she/her/hers @@@ Manuel Sanchez-Felix, PhD (he/him/his) – Halozyme ### 1630083###Presenter###VP Drug Delivery Search & Evaluation ###Halozyme ###Presenter: Manuel Sanchez-Felix, PhD (he/him/his) – Halozyme
### he/him/his @@@ Kate L. Harris (she/her/hers) – AstraZeneca ### 2323717###Presenter###Associate Principal Scientist, Biopharmaceutics###AstraZeneca###Presenter: Kate L. Harris (she/her/hers) – AstraZeneca
### she/her/hers @@@ Gerard Bruin (he/him/his) – Pharmacokinetic Sciences / Novartis ### 2296071###Presenter###Director###Pharmacokinetic Sciences / Novartis###Presenter: Gerard Bruin (he/him/his) – Pharmacokinetic Sciences / Novartis
### he/him/his @@@ Marta Venczel (she/her/hers) – Sanofi ### 2323958###Presenter###Head of Biopharmacy, EDEV Frankfurt###Sanofi###Presenter: Marta Venczel (she/her/hers) – Sanofi
### she/her/hersPresenter: Brad Minrovic, PhD – Ashland Specialty Ingredients
Presenter: Patrick Duffy, PhD – Ashland
Presenter: Rachel Galaska – Oakwood Labs
Presenter: Andreas Bramböck – MeltPrep
Presenter: Tony Listro
Presenter: Ryan Donnelly, PhD (he/him/his) – Queen's University Belfast
.png)
Presenter: Brad Minrovic, PhD – Ashland Specialty Ingredients
### @@@ Patrick Duffy, PhD – Ashland ### 2338892###Presenter###R&D Team Leader###Ashland###Presenter: Patrick Duffy, PhD – Ashland
### @@@ Rachel Galaska – Oakwood Labs ### 2313199###Presenter###Formulation Engineer, R&D###Oakwood Labs###Presenter: Rachel Galaska – Oakwood Labs
### @@@ Andreas Bramböck – MeltPrep ### 2391170###Presenter###Product Manager###MeltPrep###Presenter: Andreas Bramböck – MeltPrep
### @@@ Tony Listro ### 1728955###Presenter#########Presenter: Tony Listro
### @@@ Ryan Donnelly, PhD (he/him/his) – Queen's University Belfast ### 1615876###Presenter###Chair in Pharmaceutical Technology###Queen's University Belfast###Presenter: Ryan Donnelly, PhD (he/him/his) – Queen's University Belfast
### he/him/hisModerator & Session Organizer: Ben Boyd, PhD (he/him/his) – University of Copenhagen and Monash University
Moderator & Session Organizer: Daniel E. Schaufelberger, PhD – Johns Hopkins University
Presenter: Martina Penazzato, MD, MSc, PhD (she/her/hers) – World Health Organization
Presenter: Karl-Heinz Huemer, PhD MD (he/him/his) – khh consult
Presenter: Rene Holm, PhD, DSc – University of Southern Denmark
Presenter: Tyler Novak, PhD (he/him/his) – Gilead Sciences
Presenter: Terry Ernest, PhD (he/him/his) – Almac Group
.png)
Moderator & Session Organizer: Ben Boyd, PhD (he/him/his) – University of Copenhagen and Monash University
### he/him/his @@@ Daniel E. Schaufelberger, PhD – Johns Hopkins University ### 2323906###Moderator & Session Organizer###Adjunct Assistant Professor###Johns Hopkins University###Moderator & Session Organizer: Daniel E. Schaufelberger, PhD – Johns Hopkins University
### @@@ Martina Penazzato, MD, MSc, PhD (she/her/hers) – World Health Organization ### 2323908###Presenter###GAP-f lead###World Health Organization###Presenter: Martina Penazzato, MD, MSc, PhD (she/her/hers) – World Health Organization
### she/her/hers @@@ Karl-Heinz Huemer, PhD MD (he/him/his) – khh consult ### 2323909###Presenter###director###khh consult###Presenter: Karl-Heinz Huemer, PhD MD (he/him/his) – khh consult
### he/him/his @@@ Rene Holm, PhD, DSc – University of Southern Denmark ### 2323910###Presenter###Professor###University of Southern Denmark###Presenter: Rene Holm, PhD, DSc – University of Southern Denmark
### @@@ Tyler Novak, PhD (he/him/his) – Gilead Sciences ### 2315943###Presenter###Director - Drug Delivery Strategy and Innovation###Gilead Sciences ###Presenter: Tyler Novak, PhD (he/him/his) – Gilead Sciences
### he/him/his @@@ Terry Ernest, PhD (he/him/his) – Almac Group ### 2323913###Presenter###Director Manufacturing Science & Technology###Almac Group###Presenter: Terry Ernest, PhD (he/him/his) – Almac Group
### he/him/hisModerator & Session Organizer: Marianne Ashford, PhD (she/her/hers) – AstraZeneca
Moderator & Session Organizer: Joanna Rejman, PhD (she/her/hers) – AstraZeneca
Moderator & Session Organizer: Luis Brito, PhD (he/him/his) – Beam Therapeutics
Presenter: Dan Peer (he/him/his) – Tel Aviv University
Presenter: Alan Sabirsh, PhD (he/him/his) – AstraZeneca
Presenter: Markrete Krikorian, PhD (she/her/hers) – Beam Therapeutics
Presenter: Hyejin Kim, PhD (she/her/hers) – Emory University
Presenter: Sven Even F. Borgos, PhD (he/him/his) – SINTEF Industry, Dept Biotechnology and Nanomedicine
Presenter: Andreas Wagner, Dr (he/him/his) – Polymun Scientific GmbH
Presenter: Dolca Rogers, PhD – European Medicines Agency
Presenter: Dominik Witzigmann, PhD. (he/him/his) – NanoVation Therapeutics
.png)
Moderator & Session Organizer: Marianne Ashford, PhD (she/her/hers) – AstraZeneca
### she/her/hers @@@ Joanna Rejman, PhD (she/her/hers) – AstraZeneca ### 2296063###Moderator & Session Organizer###Director###AstraZeneca###Moderator & Session Organizer: Joanna Rejman, PhD (she/her/hers) – AstraZeneca
### she/her/hers @@@ Luis Brito, PhD (he/him/his) – Beam Therapeutics ### 2296064###Moderator & Session Organizer###Vice President###Beam Therapeutics###Moderator & Session Organizer: Luis Brito, PhD (he/him/his) – Beam Therapeutics
### he/him/his @@@ Dan Peer (he/him/his) – Tel Aviv University ### 1981099###Presenter###Professor and Director###Tel Aviv University###Presenter: Dan Peer (he/him/his) – Tel Aviv University
### he/him/his @@@ Alan Sabirsh, PhD (he/him/his) – AstraZeneca ### 2296065###Presenter###Principal Scientist###AstraZeneca###Presenter: Alan Sabirsh, PhD (he/him/his) – AstraZeneca
### he/him/his @@@ Markrete Krikorian, PhD (she/her/hers) – Beam Therapeutics ### 2343681###Presenter###Senior Scientist###Beam Therapeutics###Presenter: Markrete Krikorian, PhD (she/her/hers) – Beam Therapeutics
### she/her/hers @@@ Hyejin Kim, PhD (she/her/hers) – Emory University ### 2296067###Presenter###Assistant Professor###Emory University###Presenter: Hyejin Kim, PhD (she/her/hers) – Emory University
### she/her/hers @@@ Sven Even F. Borgos, PhD (he/him/his) – SINTEF Industry, Dept Biotechnology and Nanomedicine ### 2296068###Presenter###Senior Research Scientist###SINTEF Industry, Dept Biotechnology and Nanomedicine###Presenter: Sven Even F. Borgos, PhD (he/him/his) – SINTEF Industry, Dept Biotechnology and Nanomedicine
### he/him/his @@@ Andreas Wagner, Dr (he/him/his) – Polymun Scientific GmbH ### 2320116###Presenter###Head Liposome Technology###Polymun Scientific GmbH###Presenter: Andreas Wagner, Dr (he/him/his) – Polymun Scientific GmbH
### he/him/his @@@ Dolca Rogers, PhD – European Medicines Agency ### 2320117###Presenter###Scientific Officer (CMC)###European Medicines Agency###Presenter: Dolca Rogers, PhD – European Medicines Agency
### @@@ Dominik Witzigmann, PhD. (he/him/his) – NanoVation Therapeutics ### 2296296###Presenter###CEO###NanoVation Therapeutics ###Presenter: Dominik Witzigmann, PhD. (he/him/his) – NanoVation Therapeutics
### he/him/hisModerator & Presenter: Ali Rajabi-Siahboomi, PhD (he/him/his) – Colorcon
Moderator & Presenter: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep
Presenter: Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences
Presenter: Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd
Presenter: David J. Brayden, PhD (he/him/his) – University College Dublin
Presenter: Felix Hofmann
Presenter: Xiaoling Li, PhD (he/him/his) – University of the Pacific
Presenter: Tom Kamperman, PhD (he/him/his) – IamFluidics BV
Presenter: Johannes Khinast
Moderator & Presenter: Ali Rajabi-Siahboomi, PhD (he/him/his) – Colorcon
### he/him/his @@@ Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep ### 2015397###Moderator & Presenter###CEO###MeltPrep###Moderator & Presenter: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep
### ¯\_(ツ)_/¯ @@@ Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences ### 1655131###Presenter###Research Professor###Strathclyde Institute Of Pharmacy and BioMedical Sciences###Presenter: Clive G. Wilson, PhD – Strathclyde Institute Of Pharmacy and BioMedical Sciences
### @@@ Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd ### 2075323###Presenter###Technical Director###Shin-Etsu Chemical Company Ltd###Presenter: Anisul Quadir, PhD (he/him/his) – Shin-Etsu Chemical Company Ltd
### he/him/his @@@ David J. Brayden, PhD (he/him/his) – University College Dublin ### 1655133###Presenter###Professor of Advanced Drug Delivery###University College Dublin###Presenter: David J. Brayden, PhD (he/him/his) – University College Dublin
### he/him/his @@@ Felix Hofmann ### 2296136###Presenter#########Presenter: Felix Hofmann
### @@@ Xiaoling Li, PhD (he/him/his) – University of the Pacific ### 2296137###Presenter###Professor###University of the Pacific###Presenter: Xiaoling Li, PhD (he/him/his) – University of the Pacific
### he/him/his @@@ Tom Kamperman, PhD (he/him/his) – IamFluidics BV ### 2343374###Presenter###CTO & co-founder###IamFluidics BV###Presenter: Tom Kamperman, PhD (he/him/his) – IamFluidics BV
### he/him/his @@@ Johannes Khinast ### 2296138###Presenter#########Presenter: Johannes Khinast
###Chair: Maria José Silveira, MA (she/her/hers) – i3S- Instituto de Investigação e Inovação em Saúde, University of Porto
Speaker: Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain
Speaker: Hélder Santos, DSc (he/him/his) – University Medical Center Groningen
Speaker: Juliane Nguyen
Chair: Maria José Silveira, MA (she/her/hers) – i3S- Instituto de Investigação e Inovação em Saúde, University of Porto
### she/her/hers @@@ Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain ### 1691770###Speaker###Associate Professor###Université catholique de Louvain###Speaker: Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain
### she/her/hers @@@ Hélder Santos, DSc (he/him/his) – University Medical Center Groningen ### 1604773###Speaker###Full Professor and Head of Department of Biomaterials and Biomedical Technology###University Medical Center Groningen###Speaker: Hélder Santos, DSc (he/him/his) – University Medical Center Groningen
### he/him/his @@@ Juliane Nguyen ### 2408249###Speaker#########Speaker: Juliane Nguyen
###Chair & Presenter: Mariah Arral (she/her/hers) – Carnegie Mellon University
Chair & Presenter: Mariah Arral (she/her/hers) – Carnegie Mellon University
### she/her/hersAward Winner: Andy Lewis, BPharm (Hons) PhD (he/him/his) – Quotient Sciences
Award Winner: Marianne Ashford, PhD (she/her/hers) – AstraZeneca
Award Winner: Patrick Couvreur, PhD, PharmD (he/him/his) – University Paris-Saclay
Award Winner: Mariah Arral (she/her/hers) – Carnegie Mellon University
Award Winner: Andy Lewis, BPharm (Hons) PhD (he/him/his) – Quotient Sciences
### he/him/his @@@ Marianne Ashford, PhD (she/her/hers) – AstraZeneca ### 2296062###Award Winner###Senior Principal Scientist , Advanced Drug Delivery ###AstraZeneca ###Award Winner: Marianne Ashford, PhD (she/her/hers) – AstraZeneca
### she/her/hers @@@ Patrick Couvreur, PhD, PharmD (he/him/his) – University Paris-Saclay ### 2322549###Award Winner###Professor###University Paris-Saclay###Award Winner: Patrick Couvreur, PhD, PharmD (he/him/his) – University Paris-Saclay
### he/him/his @@@ Mariah Arral (she/her/hers) – Carnegie Mellon University ### 1671574###Award Winner###Ph.D. Candidate and NIH NRSA F31 Fellow###Carnegie Mellon University###Award Winner: Mariah Arral (she/her/hers) – Carnegie Mellon University
### she/her/hersPlenary Speaker: Luigi Naldini, MD, PhD (he/him/his) – San Raffaele Telethon Institute for Gene Therapy (SR-TIGET)
Plenary Speaker: Luigi Naldini, MD, PhD (he/him/his) – San Raffaele Telethon Institute for Gene Therapy (SR-TIGET)
### he/him/his